Local and international scientists have recorded a 27 percent resistance to anti-HIV drugs dolutegravir, exceeding levels initially observed during its trials. Before the World Health Organisation approved the drugs over a decade ago, resistance ranged from 3.9 percent to 8.6 percent, records show. Titled Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance
The authors found that overall survival in patients with newly diagnosed multiple myeloma was longest for those receiving first-line autologous stem cell transplantation.
Explore the multifaceted impact of desmoid tumors on patients’ physical, functional, and psychosocial well-being as experts emphasize effective symptom management and quality-of-life enhancements.
Explore effective approaches in handling fatigue, insomnia, and financial difficulties of patients with desmoid tumors as experts highlight psychosocial support and treatment considerations for quality care.